Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
103
NCT01519492
A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 29, 2012
Completion: Aug 31, 2012